Affymetrix Introduces Its New Scanner As Agilent Abruptly Ends Arrangement | GenomeWeb

One of the most symbiotic arrangements between competitors in the microarray space has come to an end. On Monday, Ned Barnholt, Agilent Technologies’ CEO, told BioArray News that it has concluded its long-time scanner manufacturing agreement with Affymetrix.

“We have essentially terminated the agreement,” Barnholt said, adding that the company is no longer manufacturing the scanner.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.